Edwards Lifesciences (EW) Equity Income (2011 - 2013)

Edwards Lifesciences has reported Equity Income for 3 years, with the latest figure at $200000.0 in Q2 2013.

• On a quarterly basis, Equity Income changed N/A year-over-year to $200000.0 in Q2 2013; TTM through Jun 2013 was $4.3 million, a N/A change from a year earlier, with the FY2012 full-year figure at $1.8 million, up 157.14% from the prior year.
• Equity Income was $200000.0 for Q2 2013 at Edwards Lifesciences, down from $2.0 million in the prior quarter.
• The five-year high for Equity Income was $2.0 million in Q1 2013, with the low at -$900000.0 in Q1 2011.
• Average Equity Income over 3 years is $625000.0, with a median of $500000.0 recorded in 2011.
• The sharpest annual moves came in 2012 and 2013: Equity Income advanced 16.67% in 2012, then soared 185.71% in 2013.
• Over 3 years, Equity Income stood at $1.2 million in 2011, then advanced by 16.67% to $1.4 million in 2012, then sank by 85.71% to $200000.0 in 2013.
• The last three Equity Income figures came in at $200000.0 (Q2 2013), $2.0 million (Q1 2013), and $1.4 million (Q4 2012), per Business Quant data.